Eli Lilly and Company (0Q1G)
LSE
Real-time Data
07:00 AM
Day's Range
1,020.0052 wk Range
460.00Overview - 0Q1G - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
765.25B
P/E (Trailing)
‪1.56‬
Price / Book
‪33.63‬
EV / EBITDA
‪22.90‬
Profitability
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
1.00B
Float
888.95M
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.41%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪540.00‬
200-Day Avg
‪540.00‬
Dividends
Frequency
Quarterly
Peers - 0Q1G - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0Q1GLSEEli Lilly and Company686.33BMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.40%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
- 0K9ELSENovartis AG Sponsored ADR367.33BMarket Cap+20.90%52-week change0.15P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - 0Q1G - Eli Lilly and Company
About
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines for human health. The company focuses on major therapeutic areas including cardiometabolic health, oncology, immunology, neuroscience, and rare diseases, with a portfolio that spans treatments for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
